Antibody boosting and longevity following tetanus immunization during pregnancy

Clinical Infectious Diseases

Volumn 56, Issue 5, 2013, Pages 749-750

  Fowkes, Freya J I ^a,b   McGready, Rose ^c,d,e   Johnstone Robertson, Simon ^a   Nosten, François ^c,d,e   Beeson, James G ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; TETANUS ANTIBODY; TETANUS TOXOID;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; DOSE RESPONSE; DRUG HALF LIFE; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; LETTER; NEWBORN MORTALITY; NEWBORN TETANUS; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROTECTION; TETANUS; TETANUS PROPHYLAXIS; TREATMENT RESPONSE;

ANTIBODIES, BACTERIAL; CLOSTRIDIUM TETANI; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; PREGNANCY; TETANUS; TETANUS TOXOID; VACCINATION;

EID: 84873675437     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis979     Document Type: Letter

References (8)

1. World Health Organization. Tetanus vaccine: WHO position paper. Wkly Epidemiological Rec 2006; 81:198-208.
2. Plotkin S, Orenstein W, Offit P. Vaccines. 5th ed. Philadelphia: WB Saunders Company.
3. World Health Organization. Maternal immunization against tetanus. In: Standards for maternal and neonatal care. Geneva, Switzerland: WHO, 2006:1-6.
4. Borrow R, Balmer P, Roper M. Immunological basis of immunisation. Module 3: tetanus, 2006. Available at: http://whqlibdoc.who.int/publications/2007/ 9789241595551-eng.pdf. Accessed 23 July 2012.
5. Fowkes FJ, McGready R, Cross NJ, et al. New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women. J Infect Dis 2012; 206:1612-21.
6. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007; 357:1903-15.
7. Rogerson SJ, Wijesinghe RS, Meshnick SR. Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria. Lancet Infect Dis 2010; 10:51-9.
8. Roper MH, Vandelaer JH, Gasse FL. Maternal and neonatal tetanus. Lancet 2007; 370:1947-59.